SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Centers for Disease Control and Prevention. Prevalence of disabilities and associated health conditions among adults: United States, 1999 [published erratum appears in MMWR Morb Mortal Wkly Rep 2001;50:149]. MMWR Morb Mortal Wkly Rep 2001; 50: 1205.
  • 2
    Dunlop DD, Manheim LM, Song J, Chang RW. Arthritis prevalence and activity limitations in older adults. Arthritis Rheum 2001; 44: 21221.
  • 3
    Del Rincon I, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum 2001; 44: 273745.
  • 4
    Lapsley HM, March LM, Tribe KL, Cross MJ, Courtenay BG, Brooks PM, and the Arthritis Cost and Outcome Project Group. Living with rheumatoid arthritis: expenditures, health status, and social impact on patients. Ann Rheum Dis 2002; 61: 81821.
  • 5
    Mili F, Helmick CG, Zack MM. Prevalence of arthritis: analysis of data from the US Behavioral Risk Factor Surveillance System, 1996–99. J Rheumatol 2002; 29: 19818.
  • 6
    Mokdad AH, Ford ES, Bowman BA, Dietz WH, Vinicor F, Bales VS, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 2003; 289: 769.
  • 7
    Yelin E, Cisternas MG, Pasta DJ, Trupin L, Murphy L, Helmick CG. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates. Arthritis Rheum 2004; 50: 231726.
  • 8
    Yelin E, Wanke LA. An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline. Arthritis Rheum 1999; 42: 120918.
  • 9
    Lubeck DP. A review of the direct costs of rheumatoid arthritis: managed care versus fee-for-service settings. Pharmacoeconomics 2001; 19: 8118.
  • 10
    US Department of Health and Human Services. Healthy people 2010: objectives for improving health. 2nd ed. Washington (DC): US Government Printing Office; 2000.
  • 11
    Greene WH. Econometric analysis. 4th ed. Upper Saddle River (NJ): Prentice Hall; 2000. p. 880.
  • 12
    Russell LB, Teutsch SM, Kumar R, Dey A, Milan E. Preventable smoking and exercise-related hospital admissions: a model based on the NHEFS. Am J Prev Med 2001; 20: 2634.
  • 13
    Russell LB, Valiyeva E, Carson JL. Effects of prehypertension on admissions and deaths: a simulation. Arch Intern Med 2004; 164: 211924.
  • 14
    Russell LB, Carson JL, Taylor WC, Milan E, Dey A, Jagannathan R. Modeling all-cause mortality: projections of the impact of smoking cessation based on the NHEFS: NHANES I epidemiologic follow-up study. Am J Public Health 1998; 88: 6306.
  • 15
    Miller JE, Russell LB, Davis DM, Milan E, Carson JL, Taylor WC. Biomedical risk factors for hospital admission in older adults. Med Care 1998; 36: 41121.
  • 16
    Machlin SR, Kleinman JC, Madans JH. Validity of mortality analysis based on retrospective smoking information. Stat Med 1989; 8: 9971009.
  • 17
    Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al, and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report [published erratum appears in JAMA 2003;290:197]. JAMA 2003; 289: 256072.
  • 18
    Russell LB, Valiyeva E. Projecting the consequences of better health for older adults: final report. National Technical Information Service; 2003 Jan. Report No.: PB2004106785.
  • 19
    Hall MJ, Owings MF. 2000 National Hospital Discharge Survey: advance data from vital and health statistics; no 329. Hyattsville (MD): National Center for Health Statistics; 2002
  • 20
    Haddix A, Teutsch S, Shaffer P, Dunet D. Prevention effectiveness: a guide to decision analysis and economic evaluation. New York: Oxford; 1996.
  • 21
    Maetzel A, Li LC, Pencharz J, Tomlinson G, Bombardier C, Community Hypertension Arthritis Project Study Team. The economic burden associated with osteoarthritis, rheumatoid arthritis, and hypertension: a comparative study. Ann Rheum Dis 2004; 63: 395401.
  • 22
    Verbrugge LM, Patrick DL. Seven chronic conditions: their impact on US adults' activity levels and use of medical services. Am J Public Health 1995; 85: 17382.
  • 23
    Dunlop DD, Manheim LM, Yelin EH, Song J, Chang RW. The costs of arthritis. Arthritis Rheum 2003; 49: 10113.
  • 24
    Centers for Disease Control and Prevention. Impact of arthritis and other rheumatic conditions on the health-care system: United States, 1997. MMWR Morb Mortal Wkly Rep 1999; 48: 34953.
  • 25
    Gabriel SE, Crowson CS, Luthra HS, Wagner JL, O'Fallon WM. Modeling the lifetime costs of rheumatoid arthritis. J Rheumatol 1999; 26: 126974.
  • 26
    Dunlop DD, Manheim LM, Song J, Chang RW. Health care utilization among older adults with arthritis. Arthritis Rheum 2003; 49: 16471.
  • 27
    Arthritis Foundation, Association of State and Territorial Health Officers, CDC. National arthritis action plan: a public health strategy. Atlanta (GA): Arthritis Foundation; 1999.